MorieAGertzMDMACP

PubMed

• The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis.
  Giovanni Palladini, Wagner Zago, Phil Dolan, Gene G Kinney, Michaela Liedtke, Morie A Gertz> ;Leukemia & Lymphoma. 2024 Apr 11
• Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
  Saurabh Zanwar, Morie A Gertz, Eli Muchtar, Francis K Buadi, Taxiarchis Kourelis, Wilson Gonsalves, Ronald S Go, Suzanne Hayman, Prashant Kapoor, Moritz Binder, Josell...> ;Leukemia. 2024 Apr 9
• Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
  Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K Buadi, David Dingli, Angela Dispenzieri, Amie Fonder, Morie A Gertz, Wilson I Gonsalv...> ;Blood Cancer Journal. 2024 Mar 26
• Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week.
  Esther Gonzalez-Lopez, Ellen D McPhail, Clara Salas-Anton, Fernando Dominguez, Morie A Gertz, Angela Dispenzieri, Surendra Dasari, Paolo Milani, Laura Verga, Martha Gr...> ;Journal of the American College of Cardiology. 2024 Mar 19
• Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature review.
  Gilad Itchaki, Osnat Jarhovsky, Moshe L Gatt, Merav Leiba, Pia Raanani, Iuliana Vaxman, Jorge J Castillo, Hamza Hassan, Morie A Gertz> ;Leukemia & Lymphoma. 2024 Mar 19
• Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up.
  Nadine Abdallah, Thomas E Witzig, Shaji K Kumar, Martha Q Lacy, Suzanne R Hayman, Angela Dispenzieri, Vivek Roy, Morie A Gertz, P Leif Bergsagel, S Vincent Rajkumar> ;Leukemia. 2024 Feb 28
• 1 citations
  Mode of progression in smoldering multiple myeloma: a study of 406 patients.
  Abdallah, N., Lakshman, A., Kumar, S., Cook, J., Binder, M., Kapoor, P., Dispenzieri, A., Gertz, M., Lacy, M., Hayman, S., Buadi, F., Dingli, D., Lin, Y., Kourelis, T....> ;Blood Cancer Journal. 2024 Jan 17
• 1 citations
  Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?
  Gertz, M.> ;Hematology/oncology Clinics of North America. 2024 Apr 1
• 1 citations
  Quick consults in hematology: In support of active surveillance versus treatment of high-risk smoldering multiple myeloma outside of a clinical trial.
  Gertz, M.> ;American Journal of Hematology. 2024 Mar 1
• 2 citations
  Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
  Gertz, M.> ;American Journal of Hematology. 2024 Feb 1
• Muscle and fat composition in patients with newly diagnosed multiple myeloma.
  Abdallah, N., Nagayama, H., Takahashi, N., Gonsalves, W., Fonder, A., Dispenzieri, A., Dingli, D., Buadi, F., Lacy, M., Hobbs, M., Gertz, M., Binder, M., Kapoor, P., W...> ;Blood Cancer Journal. 2023 Dec 12
• 1 citations
  A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis.
  Dasari, S., Theis, J., Vrana, J., Leung, N., Ramirez-Alvarado, M., Charalampous, C., McPhail, E., Dispenzieri, A., Muchtar, E., Gertz, M., Kourelis, T.> ;Kidney International. 2024 Mar 1
• Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
  Charalampous, C., Goel, U., Kapoor, P., Binder, M., Buadi, F., Cook, J., Dingli, D., Dispenzieri, A., Fonder, A., Gertz, M., Gonsalves, W., Hayman, S., Hobbs, M., Hwa,...> ;Blood Cancer Journal. 2023 Dec 11
• 1 citations
  Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis.
  Ahmad Masri, Mathew S Maurer, Brian L Claggett, Ian Kulac, Marcia Waddington Cruz, Isabel Conceição, Markus Weiler, John L Berk, Morie Gertz, Julian D Gillmore, Stephe...> ;Journal of Cardiac Failure. 2023 Dec 7
• MicroRNA and long non-coding RNA analysis in IgM-monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis.
  Karan Chohan, Jonas Paludo, Surendra Dasari, Patrizia Mondello, Joseph P Novak, Jithma P Abeykoon, Kerstin Wenzl, Zhi-Zhang Yang, Shahrzad Jalali, Jordan E Krull, Este...> ;Haematologica. 2024 May 1
• Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
  Sarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q Lacy, Morie A Gertz, Francis K Buadi, Suzanne R Hayman, David Din...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Mar 1
• 1 citations
  Microvascular cardiac amyloidosis-Cardiac involvement of amyloidosis presenting as typical chest pain.
  Iuliana Vaxman, Caroline Kaufman, Amir Lerman, Morie A Gertz> ;American Journal of Hematology. 2023 Dec 1
• Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients.
  S Rajkumar, Nadine Abdallah, Arjun Lakshman, Shaji Kumar, Joselle Cook, Moritz Binder, Prashant Kapoor, Angela Dispenzieri, Morie Gertz, Martha Lacy, Suzanne Hayman, F...> ;Research Square. 2023 Oct 23
• Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodies.
  Rajshekhar Chakraborty, Paolo Milani, Giovanni Palladini, Morie Gertz> ;The Lancet. Haematology. 2023 Nov 1
• Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.
  Rivka Goldis, Batia Kaplan, Michael Arad, Angela Dispenzieri, Surendra Dasari, Olga Lesya Kukuy, Amos J Simon, Amir Dori, Efrat Shavit-Stein, Tamar Ziv, David Murray, ...> ;Clinical Chemistry and Laboratory Medicine. 2024 Feb 26
• 2 citations
  Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group.
  Michelle L Mauermann, John O Clarke, William J Litchy, Laura Obici, Isabelle Lousada, Morie A Gertz> ;Advances in Therapy. 2023 Nov 1
• Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy.
  Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, Moritz Binder, Francis K Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L Fonder, Morie A Gertz, ...> ;Blood Advances. 2023 Aug 22
• 1 citations
  Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
  Walker M Schmidt, Nirosha D Perera, Francis K Buadi, Suzanne R Hayman, Shaji K Kumar, Angela Dispenzieri, David Dingli, Joselle Cook, Martha Q Lacy, Prashant Kapoor, N...> ;Blood Cancer Journal. 2023 Aug 18
• 2 citations
  Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
  Udit Yadav, Shaji K Kumar, Linda B Baughn, Angela Dispenzieri, Patricia Greipp, Rhett Ketterling, Dragan Jevremovic, Francis K Buadi, David Dingli, Martha Q Lacy, Rafa...> ;Blood. 2023 Nov 30
• 6 citations
  Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
  Saurabh Zanwar, Matthew Ho, Yi Lin, Prashant Kapoor, Moritz Binder, Francis K Buadi, Angela Dispenzieri, David Dingli, Amie Fonder, Morie A Gertz, Wilson Gonsalves, Su...> ;American Journal of Hematology. 2023 Oct 1
• Join now to see all

Journal Articles

• Systemic Amyloidosis Recognition, Prognosis, and Therapy  
  Morie A Gertz, Angela Dispenzieri, JAMA
• Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma  
  S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
• Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell Transplantation  
  Nelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
• Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
  Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
• Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL Amyloidosis  
  Saurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature
• Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy: Failure of the Serum Free Light Chain Ratio  
  Morie A Gertz, David Dingli, Miriam Hobbs, John A Lust, Ronald S Go, Amie Fonder, Yi Lin, Shaji K Kumar, Prashant Kapoor, Taxiarchis V Kourelis, S Vincent Rajkumar, Ro..., Nature
• Comparable Outcomes Using Propylene Glycol-Free Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma  
  Morie A Gertz, Shaji K Kumar, Martha Q Lacy, Prashant Kapoor, Suzanne R Hayman, Robert C Wolf, William J Hogan, Wilson I Gonsalves, Angela A Dispenzieri, David Dingli,..., Nature
• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
• Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis  
  William J Litchy, Peter D Gorevic, Morie A Gertz, Amil M Shah, John L Berk, Peter J Dyck, The New England Journal of Medicine
• Potential new risks of lenalidomide  
  Gertz MA , Buadi FK, Leuk Lymphoma, 9/1/2014
• Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders: IWWM-7 consensus  
  Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, Garcia-Sanz R, Munshi N, Anderson KC, Terpos E, Ghobrial IM, Morel P, Maloney D, Rummel M, ..., Blood, 8/28/2014
• Risk adapted therapy for multiple myeloma: back to basics  
  Kumar SK, Gertz MA, Leuk Lymphoma, 4/22/2014
• Immunoglobulin light chain amyloidosis  
  Merlini G, Comenzo RL, Seldin DC, Wechalekar A, Gertz MA, Expert Rev Hematol, 2/1/2014
• Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma  
  Kourelis TV, Kumar SK, Srivastava G, Gertz MA , Lacy MQ, Buadi FK, Kyle RA, Dispenzieri A, Leukemia, 2/1/2014
• Genetic variants in DNA repair pathways are not associated with disease progression among multiple myeloma patients  
  Thyagarajan B, Arora M, Guan W, Barcelo H, Jackson S, Kumar S, Gertz M, Leuk Res, 11/1/2013
• Waldenstrom macroglobulinaemia: the key questions  
  D'Souza A, Ansell S, Reeder C, Gertz MA, Br J Haematol, 8/1/2013
• Second auto-SCT for treatment of relapsed multiple myeloma  
  Gonsalves WI, Gertz MA , Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, Dingli D, Hogan WJ, Kumar SK, Bone Marrow Transplant, 4/1/2013
• IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia  
  Hodge LS, Ziesmer SC, Yang ZZ, Secreto FJ, Gertz MA , Novak AJ, Ansell SM, Blood, 11/1/2012
• Quantification of clonal circulating plasma cells in relapsed multiple myeloma  
  Gonsalves WI, Morice WG, Rajkumar V, Gupta V, Timm MM, Dispenzieri A, Buadi FK, Lacy MQ, Singh PP, Kapoor P, Gertz MA , Kumar SK, Br J Haematol, 8/12/2012
• Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies  
  Sinha S, Gertz MA , Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, Dingli D, Micallef IN, Hogan WJ, Gastineau DA, Rajkumar SV, Kumar SK, Leukemia, 5/1/2012
• Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy  
  Sinha S, Lacy M, Mikhael J, Hayman S, Buadi F, Detweiler-Short K, Dispenzieri A, Gertz M , Dingli D, Rajkumar SV, Kumar SK, Leukemia, 4/1/2012
• Immunoglobulin light-chain amyloidosis: Growing recognition, new approaches to therapy, active clinical trials  
  Gertz MA, Dispenzieri A, Oncology, 1/1/2012
• Immunoglobulin light chain amyloidosis: 2012 update on diagnosis, prognosis, and treatment  
  Gertz MA, Am J Hematol, 1/1/2012
• Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma  
  Kapoor P, Kumar S, Mandrekar SJ, Laumann KM, Dispenzieri A, Lacy MQ, Dingli D, Gertz MA , Kyle RA, Greipp PR, Rajkumar SV, Witzig TE, Leukemia, 7/1/2011
• Join now to see all

Books/Book Chapters

• Multiple myeloma: diagnosis and treatment 
  Gertz MA , Rajkumar SVSpringer, New York2014
• Amyloidosis: diagnosis and treatment 
  Gertz MA , Rajkumar SVHumana Press, New York2010
• Hematologic malignancies: multiple myeloma and related plasma cell disorders 
  Gertz MA , Greipp PRSpringer, Berlin2004
• Amyloid and amyloidosis 1998 
  Kyle RA, Gertz MAEditors: Kyle RA, Gertz MA.The Parthenon Publishing Group, New York1999
• Join now to see all

Abstracts/Posters

• Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Use of Maintenance Therapy Post Autologous Stem Cell Transplantation Outside of Clinical Trial Setting for Multiple Myeloma: Single Institution Experience
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long Non-Coding RNA Expression in Waldenstrom Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Optimal Therapy for Relapsed AL Amyloidosis Post Autologous Stem Cell Transplant
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Impact of sFLC Ratio on Outcome in Patients with MM: Validating the Utility of sFLC in Response Definition
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Prospective Pilot Study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed or Relapsed/Refractory POEMS Syndrome
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Mortality of Patients with Multiple Myeloma after the Introduction of Novel Therapies in the United States
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• De novo multiple myeloma after kidney transplantation
  Safadi S, Leung N, Cosio F, Amer H, Gertz M , Rajkumar V, Hayman S, Lacy M, Dispenzieri A, Am J Kidney Dis, 5/1/2014
• Prediction of poor mobilization of autologous cd34+cells in multiple myeloma (mm): implications for risk-stratification
  Costa LJ, Nista EJ, Buadi FK, Lacy MQ, Dispenzieri A, Kramer CP, Kang Y, Gertz MA , Stuart RK, Kumar SK, Transfusion, 9/1/2013
• Electrocardiographic findings in transthyretin-related cardiac amyloidosis
  O'Donnell E, Klarich K, Olson A, Lin G, Brady P, Dispenzieri A, Gertz M , Zeldenrust S, Grogan M, J Am Coll Cardiol, 3/1/2013
• The natural history of cold agglutinin disease
  Swiecicki PL, Hegerova L, Gertz MA, Blood, 11/1/2012
• Treatment of advanced heart failure in cardiac amyloidosis with left ventricular assist device therapy
  Swiecicki PL, Edwards B, Kushwaha S, Dispenzieri A, Park S, Gertz MA, J Heart Lung Transplant, 4/1/2012
• Relapse of poems following autologous stem cell transplantation: a single center experience
  D'Souza A, Buadi FK, Lacy MQ, Gertz MA , Hayman SR, Kumar S, Dingli D, Zeldenrust SR, Dispenzieri A, Blood, 11/1/2011
• Long term outcome of renal failure in multiple myeloma following autologous stem cell transplant
  Glavey SV, Gertz MA , Dispenzieri A, Kumar S, Buadi F, Lacy M, Hayman SR, Dingli D, Hogan WJ, Gastineau DA, Leung N, Am J Kidney Dis, 4/1/2011
• Join now to see all

Lectures

• Training Program DirectorsÍ Workshop 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Training Program DirectorsÍ Workshop 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Adult Clinical Malignant Hematology 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage ... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Trainee Didactic Sessions: Bridging the Gap: How to Find Clinicians (PhD Topic) 
  60th American Society of Hematology Annual Meeting - 12/3/2018
• Trainee Didactic Sessions: How to Set Up a Clinical Research Program 
  60th American Society of Hematology Annual Meeting - 12/3/2018
• Trainee Didactic Sessions: Basic Statistics for Hematologists 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• Trainee Didactic Sessions: Mentoring and Being Mentored 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• Long-Term Survivorship with Active Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ibrutinib Therapy in Patients with Waldenstrom Macroglobulinemia: Outcomes Outside of Clinical Trial Setting 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Bortezomib, Lenalidomide and Dexamethasone (VRD) Followed By Autologous Stem Cell Transplant for Newly Diagnosed Multiple Myeloma; The Mayo Clinic Experience 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Development of Thrombocytopenia and Survival Outcomes in Newly Diagnosed Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Therapy is not indicated for high risk smoldering Waldenstrom Macroglobulinemia Debate 
  London, England - 8/1/2014
• Transplant for IgM amyloidosis 
  London, England - 8/1/2014
• Complications of IgM proteins 
  London, England - 8/1/2014
• Management Strategies for relapsed myeloma 
  Chicago, IL - 6/1/2014
• Amyloidosis 
  New York City, NY - 5/1/2014
• Initial Therapy for multiple myeloma 
  Tokyo, Japan - 4/1/2014
• Initial therapy for patients with myeloma based on Mayo Clinic criteria 
  Fukuoka, Japan - 4/1/2014
• Monoclonal Gammopathies in the Kidney 
  Herzlia, Israel - 4/1/2014
• Interesting patients of monoclonal gammopathy disorders 
  Herzlia, Israel - 4/1/2014
• Mayo Clinic Young Investigators Forum 
  Chicago, IL - 4/1/2014
• Measuring minimal residual disease in multiple myeloma 
  Abu Dhabi, United Arab Emirates - 3/1/2014
• Amyloidosis: Diagnosis & Treatment 
  Los Angeles, CA - 2/1/2014
• Therapy of Amyloidosis 
  Dallas, TX - 11/1/2013
• Join now to see all